Viewing Study NCT00973934


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2025-12-28 @ 1:31 AM
Study NCT ID: NCT00973934
Status: COMPLETED
Last Update Posted: 2014-06-10
First Post: 2009-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Magnetic Seizure Therapy (MST) for the Treatment of Major Depression
Sponsor: Sarah Lisanby
Organization:

Study Overview

Official Title: Magnetic Seizure Therapy (MST) for the Treatment of Major Depression
Status: COMPLETED
Status Verified Date: 2014-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MST-2
Brief Summary: This two-center, between-subject, randomized, double-masked study (n=20) will provide the first evidence for the antidepressant efficacy of Magnetic Seizure Therapy (MST) and contrast the therapeutic properties and side effects of two forms of MST in patients in a major depressive episode (MDE).
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
01-069 None None View